Pediatric Neurology
Volume 41, Issue 1 , Pages 27-33 , July 2009

Rolandic Mitochondrial Encephalomyelopathy and MT-ND3 Mutations

  • Klaus G.E. Werner, MD, PhD

      Affiliations

    • Division of Neurology and Pediatric Emergency Medicine, Hospital for Sick Children, Toronto, Ontario, Canada
    • Both authors contributed equally to this work.
    • ,
  • Chantal F. Morel, MD

      Affiliations

    • Division of Clinical and Metabolic Genetics, Hospital for Sick Children, Toronto, Ontario, Canada
    • Both authors contributed equally to this work.
    • ,
  • Adam Kirton, MD

      Affiliations

    • Division of Neurology, Alberta Children's Hospital, Calgary, Alberta, Canada
    • ,
  • Susanne M. Benseler, MD

      Affiliations

    • Division of Rheumatology and Pediatric Emergency Medicine, Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada
    • ,
  • John M. Shoffner, MD

      Affiliations

    • Medical Neurogenetics, Atlanta, Georgia
    • ,
  • Jane B.L. Addis, BSc

      Affiliations

    • Metabolism Research Program, Research Institute, Department of Biochemistry, Hospital for Sick Children, Toronto, Ontario, Canada
    • ,
  • Brian H. Robinson, PhD

      Affiliations

    • Metabolism Research Program, Research Institute, Department of Biochemistry, Hospital for Sick Children, Toronto, Ontario, Canada
    • ,
  • Delilah M. Burrowes, MD

      Affiliations

    • Department of Radiology, Northwestern University Feinberg School of Medicine, Chicago, Illinois
    • ,
  • Susan I. Blaser, MD

      Affiliations

    • Department of Diagnostic Imaging, Division of Neuroradiology, Hospital for Sick Children, Toronto, Ontario, Canada
    • ,
  • Leon G. Epstein, MD

      Affiliations

    • Departments of Pediatrics and Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois
    • ,
  • Annette S.J. Feigenbaum, MD

      Affiliations

    • Division of Clinical and Metabolic Genetics, Hospital for Sick Children, Toronto, Ontario, Canada
    • Corresponding Author InformationCommunications should be addressed to: Dr. Feigenbaum; Division of Clinical and Metabolic Genetics; The Hospital for Sick Children; 555 University Avenue; Toronto, Ontario M5G 1X8, Canada.

Received 27 August 2008 ,Accepted 16 February 2009.

References 

  1. Robinson BH. Lacticacidemia. Biochim Biophys Acta. 1993;1182:231–244
  2. Pitkänen S, Feigenbaum A, Laframboise R, Robinson BH. NADH-coenzyme Q reductase (complex I) deficiency: heterogeneity in phenotype and biochemical findings. J Inherit Metab Dis. 1996;19:675–686
  3. Robinson BH. Human complex I deficiency: clinical spectrum and involvement of oxygen free radicals in the pathogenicity of the defect. Biochim Biophys Acta. 1998;1364:271–286
  4. Kirby DM, Crawford M, Cleary MA, Dahl HH, Dennett X, Thorburn DR. Respiratory chain complex I deficiency: an underdiagnosed energy generation disorder. Neurology. 1999;52:1255–1264
  5. Loeffen JL, Smeitink JA, Trijbels JM, et al. Isolated complex I deficiency in children: clinical, biochemical and genetic aspects. Hum Mutat. 2000;15:123–134
  6. Bénit P, Chretien D, Kadhom N, et al. Large-scale deletion and point mutations of the nuclear NDUFV1 and NDUFS1 genes in mitochondrial complex I deficiency. Am J Hum Genet. 2001;68:1344–1352
  7. Pavlakis SG, Phillips PC, DiMauro S, De Vivo DC, Rowland LP. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome. Ann Neurol. 1984;16:481–488
  8. Finsterer J. Mitochondriopathies. Eur J Neurol. 2004;11:163–186
  9. Goto Y, Nonaka I, Horai S. A mutation in the tRNALeu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature. 1990;348:651–653
  10. Goto Y, Nonaka I, Horai S. A new mtDNA mutation associated with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). Biochim Biophys Acta. 1991;1097:238–240
  11. Morten KJ, Cooper JM, Brown GK, Lake BD, Pike D, Poulton J. A new point mutation associated with mitochondrial encephalomyopathy. Hum Mol Genet. 1993;2:2081–2087
  12. Ruiz-Pesini E, Lott MT, Procaccio V, et al. An enhanced MITOMAP with a global mtDNA mutational phylogeny. Nucleic Acids Res. 2007;35(database issue):D823–D828
  13. Lebon S, Chol M, Benit P, et al. Recurrent de novo mitochondrial DNA mutations in respiratory chain deficiency. J Med Genet. 2003;40:896–899
  14. Crimi M, Papadimitriou A, Galbiati S, et al. A new mitochondrial DNA mutation in ND3 gene causing severe Leigh syndrome with early lethality. Pediatr Res. 2004;55:842–846
  15. McFarland R, Kirby DM, Fowler KJ, et al. De novo mutations in the mitochondrial ND3 gene as a cause of infantile mitochondrial encephalopathy and complex I deficiency. Ann Neurol. 2004;55:58–64
  16. Leshinsky-Silver E, Lev D, Tzofi-Berman Z, et al. Fulminant neurologic deterioration in a neonate with Leigh syndrome due to a maternally transmitted missense mutation in the mitochondrial ND3 gene. Biochem Biophys Res Commun. 2005;334:582–587
  17. Taylor RW, Singh-Kler R, Hayes CM, Smith PE, Turnbull DM. Progressive mitochondrial disease resulting from a novel missense mutation in the mitochondrial DNA ND3 gene. Ann Neurol. 2001;50:104–107
  18. Ingman M, Gyllensten U. mtDB: Human Mitochondrial Genome Database, a resource for population genetics and medical sciences. Nucleic Acids Res. 2006;34(database issue):D749–D751
  19. Robinson BH, Glerum DM, Chow W, Petrova-Benedict R, Lightowlers R, Capaldi R. The use of skin fibroblast cultures in the detection of respiratory chain defects in patients with lacticacidemia. Pediatr Res. 1990;28:549–555
  20. Rahman S, Blok RB, Dahl HH, et al. Leigh syndrome: clinical features and biochemical and DNA abnormalities. Ann Neurol. 1996;39:343–351
  21. Chae JH, Lee JS, Kim KJ, et al. A novel ND3 mitochondrial DNA mutation in three Korean children with basal ganglia lesions and complex I deficiency. Pediatr Res. 2007;61:622–624
  22. Sarzi E, Brown MD, Lebon S, et al. A novel recurrent mitochondrial DNA mutation in ND3 gene is associated with isolated complex I deficiency causing Leigh syndrome and dystonia. Am J Med Genet A. 2007;143:33–41
  23. Cockerell OC, Rothwell J, Thompson PD, Marsden CD, Shorvon SD. Clinical and physiological features of epilepsia partialis continua: cases ascertained in the UK. Brain. 1996;119:393–407
  24. Galkin A, Meyer B, Wittig I, et al. Identification of the mitochondrial ND3 subunit as a structural component involved in the active/deactive enzyme transition of respiratory complex I. J Biol Chem. 2008;283:20907–20913

PII: S0887-8994(09)00084-8

doi: 10.1016/j.pediatrneurol.2009.02.010

Pediatric Neurology
Volume 41, Issue 1 , Pages 27-33 , July 2009

Article Tools

* Image Usage & Resolution